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ABSTRACT 
An incidental finding of an intense focus of 
18F-Fluorodeoxyglucose (FDG) pulmonary uptake on positron emission 
tomography (PET) without detectable lesions on computed tomography (CT) is highly suggestive of FDG microembolus. 
Its microscopic nature means it is undetectable on CT. It is an artefact attributable to 
18F-FDG-tracer contamination at 
the injection site. This paper reports a case of a 61 year-old lady with a past history of breast carcinoma, in whom 
follow-up PET/CT images demonstrated an incidental intense FDG pulmonary abnormality. A follow-up PET/CT seven 
months later demonstrated complete resolution of the abnormality. © 2010 Biomedical Imaging and Intervention Journal. 
All rights reserved. 
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INTRODUCTION 
Positron  Emission  Tomography/Computed 
Tomography (PET/CT) fusion imaging is a novel multi-
modality  technology  that  allows  the  correlation  of 
findings  from  two  concurrent  imaging  modalities  in  a 
comprehensive  examination.  As  altered  glucose 
metabolism  is  characteristic  for  many  malignancies, 
FDG-PET  is  mostly  used  in  oncology  for  staging  and 
therapy monitoring. It can also be seen as a physiologic 
activity in the bowel or muscles, in benign disease such 
as  inflammation  or  post-traumatic  reactive  changes,  or 
simply represent artefactual uptake from inaccurate CT 
attenuation  correction  in  dense  objects,  often  mistaken 
for cancer [1–3]. 
The experienced PET/CT reader mostly manages to 
differentiate malignant from non-malignant FDG uptake 
based  on  accurate  interpretation  of  the  PET  data  by 
correlating with the CT anatomic information [1–3]. This 
paper documents an example of a false positive PET/CT 
interpretation  of  an  artefact,  which  may  at  times  be 
erroneously diagnosed as a pathological entity. 
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Figure 1 Correlative axial images of CT (left) and PET (right) (February 2007): The PET image displayed an 
intense 
18F-FDG  focus  in  the  apical  segment  of  the  left  lower  lobe  which  is  imperceptible  on  the 
corresponding CT image. It has maximal SUV of 17.9 and an estimated maximal diameter of 2.5 cm. 
 
Figure 2 Correlative axial images of CT (left) and PET (right) (September 2007): The previously documented 
focal FDG uptake in the left lung has resolved, likely to represent FDG microembolus rather than 
metastatic disease. 
CASE REPORT  
This case report looks at a 61 year-old lady who has 
a history of nodal positive right breast cancer treated by 
surgery and chemotherapy in 1996. She was referred for 
a  PET/CT  in  February  2007  with  the  query  of 
locoregional recurrence because of recurrent chest wall 
pain. PET/CT study revealed an intense 
18F-FDG focus 
in  the  apical  segment  of  the  left  lower  lobe  on  PET 
without  any  perceptible  corresponding  CT  lesion 
(Figure 1). By virtue of the lesion-imperceptibility on the 
correlative CT, a provisional diagnosis of an iatrogenic 
FDG  microembolus  was  made  and  the  patient  was 
managed  conservatively.  A  follow-up  PET/CT  done 
seven months later demonstrated complete resolution of 
the PET abnormality and confirmed its benign aetiology 
(Figure 2). 
DISCUSSION 
In this case, the intense 
18F-FDG focus in the left 
lower  lobe  is  highly  suggestive  of  thromboembolus 
phenomenon  attributed  to  a  tagged  platelet  or  mixed 
nature rather than red blood cells [3, 5]. This detected 
FDG activity was no longer apparent on the follow-up 
PET/CT  done  seven  months  later.  Of  late,  there  have 
been a number of similar reported cases and all the cases 
exhibited  similar  features  on  the  PET/CT  correlative 
images [1–3]. 
An intense 
18F-FDG-PET focus without a detectable 
CT  abnormality  may  rarely  be  a  result  of  an  early 
imperceptible  structural  lesion  [1–4].  Complete 
resolution of such an intense FDG focus in all the known 
reported instances is, therefore, essential to establish the 
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In principle, an intense FDG focus is not entirely 
specific for malignancy. In general, CT is more sensitive 
than  FDG-PET  in  the  detection  of  pulmonary  lesions, 
given  its  superior  spatial  resolution  [4].  Therefore  the 
absence  of  structural  lesions  on  CT  alerts  to  the 
possibility  that  the  focal  FDG-PET  intensity  is  not  a 
genuine abnormality. 
This is in line with the fact that more than one-third 
of scintigraphic equivocal lesions were correctly triaged 
by analysis of the morphological and anatomical details 
on the correlative CT study [4]. 
Incidence  of  microembolus  formation  involving 
radiotracer injection has also  been reported in patients 
with  abnormal  peripheral  venous  system  and  difficult 
phlebotomy, following the usage of an old intravenous 
cannula, or the presence of a hypercoagulability state in 
which the FDG is mixed with blood products prior to 
injection [5]. The phenomenon may be reduced by using 
a new intravenous cannula, avoiding the withdrawal of 
blood  prior  to  FDG  injection  and  adopting  a  good 
intravenous technique. 
CONCLUSION 
An  intense 
18F-FDG-PET  pulmonary  abnormality 
without detectable lesions on the correlative CT study is 
highly  suggestive  of  artefacts  caused  by  FDG 
microembolus. This report emphasises the importance of 
becoming  familiar  with  the  potential  pitfalls  of  false-
positive interpretations of PET. 
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